98 results match your criteria: ""Emile Muller" Hospital[Affiliation]"

Low atrial rhythm (LAR) is an ectopic rhythm originating in the lower part of the right or left atrium. Prior observational studies attempted to quantify the prevalence of low atrial rhythm in the pediatric population, but the observed prevalence was highly variable with relatively small sample sizes. We aimed to characterize low atrial rhythm and determine its prevalence in a large population of 24,316 asymptomatic children from northwestern Transylvania.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores the effectiveness and safety of off-label targeted therapies in patients with rare autoimmune and inflammatory diseases.
  • A total of 100 patients were enrolled, primarily middle-aged women, with a variety of targeted therapies being used and a significant proportion still on corticosteroid treatments.
  • Results indicated that 56% of patients found the treatment effective, leading to a significant reduction in corticosteroid dosage, while the overall tolerance of these therapies was deemed acceptable despite some serious health incidents.
View Article and Find Full Text PDF

Introduction: Mucormycosis is a rare systemic fungal infection, mainly observed in immunocompromised patients. It is responsible for surface and deep tissue destruction leading to perforations and hemorrhage. Its pathogenesis represented by an angio-invasion is at the origin of a local infarction and a vascular thrombosis.

View Article and Find Full Text PDF

The global prevalence of vitamin D deficiency is more than 20%, and the main causes include insufficient intake, reduced absorption, abnormal metabolism, or resistance to its effects. The levels of serum vitamin D appear to influence cardiovascular risk, and the mechanism involved is linked to the transient outward current and the ultrarapid delayed rectifier K+ current densities, activated through the nuclear vitamin D receptor and Akt pathway. A significant number of studies have correlated vitamin D deficiency with an increased risk of developing cardiac arrhythmias and sudden cardiac death.

View Article and Find Full Text PDF

Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial.

Intensive Care Med

July 2022

Service de Médecine Intensive-Réanimation, Institut de Cardiologie, APHP Hôpital Pitié-Salpêtrière, 75013, Paris, France.

Purpose: Epidemiologic studies have documented lower rates of active smokers compared to former or non-smokers in symptomatic patients affected by coronavirus disease 2019 (COVID-19). We assessed the efficacy and safety of nicotine administered by a transdermal patch in critically ill patients with COVID-19 pneumonia.

Methods: In this multicentre, double-blind, placebo-controlled trial conducted in 18 intensive care units in France, we randomly assigned adult patients (non-smokers, non-vapers or who had quit smoking/vaping for at least 12 months) with proven COVID-19 pneumonia receiving invasive mechanical ventilation for up to 72 h to receive transdermal patches containing either nicotine at a daily dose of 14 mg or placebo until 48 h following successful weaning from mechanical ventilation or for a maximum of 30 days, followed by 3-week dose tapering by 3.

View Article and Find Full Text PDF

Beta-blockers for the treatment of arrhythmias: Bisoprolol - a systematic review.

Ann Pharm Fr

September 2022

Cardiology Department, CHU de Rennes, 35000 Rennes, France.

Objectives: Beta-blockers have long been successfully used for the treatment of both supraventricular and ventricular arrhythmias. However, differences exist between their chemical structure, pharmacokinetic and pharmacodynamic properties (absorption, bioavailability, metabolism, hydrophilic or lipophilic character, selective or non-selective nature, the presence or absence of intrinsic sympathomimetic activity), which may confer different antiarrhythmic properties to different beta-blockers. The aim of this study was to analyze the current existing evidence for bisoprolol for the treatment of both supraventricular and ventricular arrhythmias.

View Article and Find Full Text PDF
Article Synopsis
  • This study compares traditional nursing techniques with autonomous robotic applications for managing patients with advanced dementia.
  • Researchers searched major databases for relevant articles, ultimately selecting 23 studies that included 8 focusing on nursing techniques and 15 on robotic applications.
  • Findings show that robotic applications are not only feasible and cost-effective but also offer significant benefits for both patients and the healthcare system.
View Article and Find Full Text PDF

Over recent decades, a new antibiotic crisis has been unfolding due to a decreased research in this domain, a low return of investment for the companies that developed the drug, a lengthy and difficult research process, a low success rate for candidate molecules, an increased use of antibiotics in farms and an overall inappropriate use of antibiotics. This has led to a series of pathogens developing antibiotic resistance, which poses severe threats to public health systems while also driving up the costs of hospitalization and treatment. Moreover, without proper action and collaboration between academic and health institutions, a catastrophic trend might develop, with the possibility of returning to a pre-antibiotic era.

View Article and Find Full Text PDF

Although noninvasive ventilation (NIV) may prevent reintubation in patients at high risk of extubation failure in ICUs, this oxygenation strategy has not been specifically assessed in obese patients. We hypothesized that NIV may decrease the risk of reintubation in obese patients compared with high-flow nasal oxygen. analysis of a multicenter randomized controlled trial (not prespecified) comparing NIV alternating with high-flow nasal oxygen versus high-flow nasal oxygen alone after extubation, with the aim of assessing NIV effects according to patient body mass index (BMI).

View Article and Find Full Text PDF

A simple clinical score to promote and enhance ferroportin disease screening.

J Hepatol

March 2022

Univ Rennes, CHU Rennes, INSERM CIC1414, F-35000, Rennes, France; National Reference Center for Hemochromatosis and iron metabolism disorder, CHU Rennes, F-35000, Rennes, France; INSERM, Univ Rennes, CHU Rennes, UMR1241, Institut NuMeCan, Rennes, France.

Article Synopsis
  • Ferroportin disease is a rare genetic disorder causing excess iron in the body, possibly more common than previously thought, but often underdiagnosed due to high costs and unclear genetic testing criteria.
  • The study developed a scoring system based on various clinical factors to improve screening for this condition, using data from over 1,300 patients to create a weighted score that aids diagnosis.
  • The scoring system showed a sensitivity of 93.6% and is proposed for use in regular clinical practice to help identify and manage patients with ferroportin disease effectively.
View Article and Find Full Text PDF

Background: In Europe, few data regarding the characteristics of EGFR exon 20 insertion (20ins) mutations in non-small cell lung cancer (NSCLC) are available.

Objective: Using a large real-world cohort, we assessed the incidence, characteristics, and outcomes of patients with non-squamous (nsq) NSCLC harboring EGFR exon 20ins.

Patients And Methods: The Epidemio-Strategy and Medical Economics advanced and metastatic lung cancer data platform including advanced/metastatic nsqNSCLC patients from January 2015 was analyzed (cut-off date: June 30, 2020).

View Article and Find Full Text PDF
Article Synopsis
  • This study investigated if colchicine, an anti-inflammatory medication, could reduce heart damage and remodeling after a ST-segment-elevation myocardial infarction (a type of heart attack) by comparing it to a placebo in a double-blind trial.
  • The trial included 192 patients, with no significant differences in heart damage or remodeling observed between the colchicine and placebo groups at both 5 days and 3 months post-treatment.
  • However, patients taking colchicine experienced higher rates of gastrointestinal side effects compared to those on the placebo, suggesting a potential drawback of the treatment.
View Article and Find Full Text PDF
Article Synopsis
  • FOLFIRINOX, a chemotherapy combination used for treating pancreatic adenocarcinoma, was analyzed for its effectiveness, measuring progression-free survival (PFS) and overall survival (OS) in patients with metastatic cancer.
  • A study involving 136 patients showed a median PFS of approximately 6 months and a median OS of nearly 9 months, identifying factors that could influence survival outcomes.
  • The findings suggested that using granulocyte colony-stimulating factor can improve survival rates, while higher doses of oxaliplatin and fluorouracil may have negative impacts on patient outcomes.
View Article and Find Full Text PDF

Objectives: Immune checkpoint inhibitors have become the standard of care for metastatic non-small-cell lung cancer (NSCLC) progressing during or after platinum-based chemotherapy. Real-world clinical practice tends to represent more diverse patient characteristics than randomized clinical trials. We sought to evaluate overall survival (OS) outcomes in the total study population and in key subsets of patients who received nivolumab for previously treated advanced NSCLC in real-world settings in France, Germany, or Canada.

View Article and Find Full Text PDF

Hyperemesis gravidarum (HG) refers to severe nausea and emesis noted during pregnancy. However, no consensus exists on the specific diagnostic criteria that can be used for this condition. The aim of the present systematic review was to summarize the available evidence regarding the severe complications observed during HG with a heightened risk of fatality.

View Article and Find Full Text PDF

Background And Purpose: Direct aspiration (DA) using large-bore distal aspiration catheters is an established strategy for the endovascular thrombectomy (EVT) of large-vessel occlusion stroke (LVOS). However, the performance of individual catheters like SOFIA has yet to be examined.

Methods: We present a cohort of 144 consecutive patients treated with first-line DA and SOFIA 6 F Plus catheter for LVOS.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to establish standard P-wave values on electrocardiograms (ECGs) for children and adolescents in Eastern Europe, focusing on those from Transylvania, Romania.
  • A total of 22,411 ECGs from participants aged 6 to 18 were analyzed, revealing key metrics like average P-wave duration, which was found to be 88 ms, and how these values correlated with age and heart rate but not with gender.
  • The results will help create guidelines for interpreting pediatric ECGs, providing a reference for healthcare professionals working with youth in this region.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the clinical and genetic characteristics of β-galactosidase deficiency, focusing on two conditions: GM1-gangliosidosis and mucopolysaccharidosis IVB (MPSIVB).
  • Researchers analyzed data from 52 patients, finding a range of clinical symptoms in GM1-gangliosidosis from severe prenatal forms to adult onset.
  • The study identified numerous genetic variants, including 18 new ones, linking specific variants to distinct types of these disorders, ultimately aiming to improve patient classification and management.
View Article and Find Full Text PDF

Background: As aging was found to be associated with increased D-dimer levels, the question arose whether D-dimer measurement was useful in the diagnostic strategy of venous thromboembolism (VTE) in elderly patients.

Aim Of The Study: To compare retrospectively the performance of six diagnostic strategies based on the three-level Wells scores and various cut-off levels for D-dimer, evaluated using the HemosIL D-Dimer HS 500 assay, in a derivation cohort of 644 outpatients with non-high pretest probability (PTP) of VTE. The clinical usefulness of the best-performing strategy was then confirmed in a multicenter validation study involving 1255 consecutive outpatients with non-high PTP.

View Article and Find Full Text PDF
Article Synopsis
  • Inflammatory processes significantly worsen myocardial damage during ischemia-reperfusion injury in STEMI, leading to serious complications like heart failure and poor recovery.
  • Colchicine, known for its strong anti-inflammatory effects, has shown a promising 50% reduction in infarct size in a phase II trial, compared to placebo, for acute STEMI patients undergoing primary percutaneous coronary intervention (PPCI).
  • The ongoing COVERT-MI trial aims to confirm these findings by comparing a short course of colchicine treatment to placebo in STEMI patients, measuring infarct size and other cardiac health indicators over 5 days.
View Article and Find Full Text PDF
Article Synopsis
  • The text discusses a study aimed at evaluating non-invasive oxygenation treatments for ICU patients with acute respiratory failure who have do-not-intubate orders, focusing on quality of life and discomfort, not just survival.
  • It outlines a multicentre observational study comparing different oxygenation strategies: high-flow nasal oxygen therapy (HFOT), NIV switching with HFOT, and NIV with standard oxygen, with a goal to include at least 330 patients.
  • The study has received ethical approval, will involve informed consent from participants, and aims to publish findings in peer-reviewed journals with trial registration number NCT03673631.
View Article and Find Full Text PDF

Objectives: Therapeutic alliance (TA) is the agreement between caregiver and patient during the care process. Therapeutic adherence is a major issue for the management of Juvenile Idiopathic Arthritis (JIA) requiring child's strong ability to follow treatments. The aim of this study was to evaluate the relationship between TA and adherence in patients with JIA.

View Article and Find Full Text PDF

EVIDENS is an ongoing, prospective, non-interventional study evaluating the effectiveness and safety of nivolumab in lung cancer patients in France (ClinicalTrials.gov NCT03382496). Adults with a pathologically confirmed diagnosis of lung cancer and initiating treatment with nivolumab were recruited from 146 sites in France.

View Article and Find Full Text PDF